Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $31.87 in the prior trading day, RxSight Inc (NASDAQ: RXST) closed at $29.81, down -6.46%. In other words, the price has decreased by -$6.46 from its previous closing price. On the day, 0.6 million shares were traded. RXST stock price reached its highest trading level at $32.245 during the session, while it also had its lowest trading level at $29.65.
Ratios:
Our goal is to gain a better understanding of RXST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.71 and its Current Ratio is at 12.67. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 20, 2024, Downgraded its rating to Hold and sets its target price to $40 from $65 previously.
On December 11, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $56 to $42.
On December 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $52.UBS initiated its Buy rating on December 06, 2024, with a $52 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 22 ’25 when Maniar Shweta sold 3,519 shares for $30.87 per share. The transaction valued at 108,618 led to the insider holds 7,383 shares of the business.
Maniar Shweta bought 3,519 shares of RXST for $108,618 on Jan 22 ’25. On Jan 16 ’25, another insider, Corley Jesse Anderson, who serves as the Director of the company, bought 1,767 shares for $31.13 each. As a result, the insider paid 55,004 and bolstered with 3,210 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 1201477120 and an Enterprise Value of 975660096. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.36 while its Price-to-Book (P/B) ratio in mrq is 4.33. Its current Enterprise Value per Revenue stands at 7.605 whereas that against EBITDA is -27.899.
Stock Price History:
The Beta on a monthly basis for RXST is 1.18, which has changed by -0.46605766 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $66.54, while it has fallen to a 52-week low of $26.29. The 50-Day Moving Average of the stock is -14.03%, while the 200-Day Moving Average is calculated to be -38.09%.
Shares Statistics:
The stock has traded on average 674.00K shares per day over the past 3-months and 442770 shares per day over the last 10 days, according to various share statistics. A total of 40.25M shares are outstanding, with a floating share count of 38.12M. Insiders hold about 5.43% of the company’s shares, while institutions hold 87.57% stake in the company. Shares short for RXST as of 1738281600 were 2315175 with a Short Ratio of 3.43, compared to 1735603200 on 2571911. Therefore, it implies a Short% of Shares Outstanding of 2315175 and a Short% of Float of 6.02.
